Biocon has informed that it enclosed Company statement regarding ‘The U.S. Food and Drug Administration (FDA) conducted an inspection at Biocon Biologics Limited’s Biocon Campus (Site 1) facility between February 20-28, 2024.’ More details enclosed.
The above information is a part of company’s filings submitted to BSE.